HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kun Ni Selected Research

1- ((4- methylsulfonyl)phenyl)- 3- trifluoromethyl- 5- (4- fluorophenyl)pyrazole

6/2019COX-2 contributed to the remifentanil-induced hyperalgesia related to ephrinB/EphB signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kun Ni Research Topics

Disease

5Hyperalgesia
01/2022 - 11/2018
4Pain (Aches)
06/2019 - 06/2014
3Bone Neoplasms (Bone Cancer)
11/2018 - 06/2014
1Ototoxicity
01/2022
1Postoperative Pain
01/2022
1CHARGE Syndrome
11/2021
1Laryngostenosis
11/2021
1Fistula
11/2021
1Congenital Abnormalities (Deformity)
11/2021
1Nervous System Diseases (Neurological Disorders)
10/2021
1Paralysis (Palsy)
10/2021
1Neoplasms (Cancer)
04/2021
1Hyperbilirubinemia
12/2020
1Acidosis
12/2020
1Neonatal Hyperbilirubinemia
12/2020
1Fibrosarcoma
11/2018
1Deafness (Deaf Mutism)
01/2018
1Rupture
10/2015
1Cancer Pain
06/2014
1Hemangioma (Angioma)
09/2013
1Neoplasm Metastasis (Metastasis)
01/2013
1Leukoplakia
01/2013
1Carcinoma (Carcinomatosis)
01/2013
1Allergic Rhinitis
10/2012
1Otitis Media with Effusion
10/2012
1Otitis Media
10/2012
1Hypertrophy
10/2012
1Hemorrhage
07/2012

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
04/2021 - 01/2013
4Messenger RNA (mRNA)IBA
04/2021 - 01/2013
4N-Methylaspartate (NMDA)IBA
04/2021 - 06/2014
3N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
04/2021 - 06/2014
2salicylhydroxamic acid (SHAM)IBA
04/2021 - 11/2018
2Analgesics (Analgesic Drugs)IBA
04/2021 - 07/2014
2Peptides (Polypeptides)IBA
07/2014 - 06/2014
1salubrinalIBA
01/2022
1Transcription Factors (Transcription Factor)IBA
01/2022
1Cisplatin (Platino)FDA LinkGeneric
01/2022
1Small Interfering RNA (siRNA)IBA
01/2022
1CCAAT-Enhancer-Binding ProteinsIBA
01/2022
1CytokinesIBA
01/2022
1Peptide Initiation Factors (Initiation Factor)IBA
01/2022
1Methylene Blue (Methylthioninium Chloride)FDA Link
11/2021
1SuspensionsIBA
11/2021
1Riboflavin (Vitamin B2)FDA LinkGeneric
10/2021
1OligodeoxyribonucleotidesIBA
04/2021
1BilirubinIBA
12/2020
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
12/2020
1N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA
06/2019
1Remifentanil (Ultiva)FDA Link
06/2019
11- ((4- methylsulfonyl)phenyl)- 3- trifluoromethyl- 5- (4- fluorophenyl)pyrazoleIBA
06/2019
1Opiate AlkaloidsIBA
06/2019
1Cholecystokinin B ReceptorIBA
01/2019
15-HT2B Serotonin ReceptorIBA
01/2019
1YM 022IBA
01/2019
12- amino- 4- (4- fluoronaphth- 1- yl)- 6- isopropylpyrimidineIBA
01/2019
1Protein Kinases (Protein Kinase)IBA
01/2019
11- (5- (2- thenyloxy)- 1H- indol- 3- yl)propan- 2- amineIBA
01/2019
1SincalideFDA Link
01/2019
1Cholecystokinin (Pancreozymin)IBA
01/2019
1Dihydrotachysterol (AT 10)IBA
11/2018
1Phosphotransferases (Kinase)IBA
11/2018
1alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA
11/2018
1Protein Isoforms (Isoforms)IBA
01/2018
1Oxygen (Dioxygen)IBA
10/2015
1Propranolol (Inderal)FDA LinkGeneric
09/2013
1Extracellular Matrix ProteinsIBA
01/2013
1Hormones (Hormone)IBA
10/2012
1SteroidsIBA
10/2012
1Ointments (Pastes)IBA
07/2012
1Calcium Sulfate (Alabaster)IBA
07/2012

Therapy/Procedure

5Spinal Injections
06/2019 - 06/2014
2Therapeutics
09/2013 - 10/2012
1Aftercare (After-Treatment)
11/2021
1Cochlear Implants (Cochlear Implant)
11/2021
1Laryngoscopes
11/2021
1Cochlear Implantation
11/2021